04:20 AM EDT, 05/07/2026 (MT Newswires) -- Swedish biopharmaceutical company Kuros Biosciences (KURN.SW) appointed I.V. Hall as chief operating officer, effective June 1.

Hall was most recently the chief executive of Next Science, according to a Thursday release. He will succeed Sjoerd Musters, who will remain in the company through Aug. 1.

Ämnen i artikeln

Kuros Biosciences AG

Senast

20,18

1 dag %

−1,27%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån